Literature DB >> 11777547

IL-1 genes in myasthenia gravis: IL-1A -889 polymorphism associated with sex and age of disease onset.

Francesca L Sciacca1, Cinzia Ferri, Fabrizio Veglia, Francesca Andreetta, Renato Mantegazza, Ferdinando Cornelio, Diego Franciotta, Giovanni Piccolo, Vittorio Cosi, Anna P Batocchi, Amelia Evoli, Luigi M E Grimaldi.   

Abstract

Myasthenia gravis (MG) is a multifactorial autoimmune disease of the neuromuscular junction. We investigated the relation between four polymorphisms of the interleukin (IL)-1 gene cluster on 2q12-22, and MG susceptibility and clinical features in a large cohort of individuals. No polymorphism was associated with MG susceptibility. However, the IL-1A -889 CC genotype was associated with early disease onset (p=0.0044) in the whole MG group and the subgroup of CC males developed MG about 18 years earlier than males carrying other IL-1A -889 genotypes (p=0.022). This finding suggests that IL-1A is a disease modifier in MG, or is in linkage disequilibrium with an unknown locus on chromosome 2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11777547     DOI: 10.1016/s0165-5728(01)00449-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

1.  The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis.

Authors:  Amel Meraouna; Geraldine Cizeron-Clairac; Rozen Le Panse; Jacky Bismuth; Frederique Truffault; Chantal Tallaksen; Sonia Berrih-Aknin
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

2.  Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus.

Authors:  Elena Sánchez; José M Sabio; José L Callejas; Enrique de Ramón; Rosa Garcia-Portales; Francisco J García-Hernández; Juan Jiménez-Alonso; Ma Francisca González-Escribano; Javier Martín; Bobby P Koeleman
Journal:  BMC Med Genet       Date:  2006-05-23       Impact factor: 2.103

3.  Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis.

Authors:  Cynthia A Cordeiro; Paula R Moreira; Germano C Costa; Walderez O Dutra; Wesley R Campos; Fernando Oréfice; Antônio L Teixeira
Journal:  Mol Vis       Date:  2008-10-12       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.